General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
INTC, MSFT, META, PFE, TSLA: Top Trending Stocks Today- Benzinga | news.google.com • |
Volatility Ahead? September Seasonality, FOMC, Triple-Witching Loom | zacks.com • |
Tesla Stock Snapped a 5-Day Winning Streak. Here’s What Did It | news.google.com • |
Tesla Inc. stock falls Monday, underperforms market | news.google.com • |
5 Oversold Stocks to Buy Right Now | marketbeat.com • |
Tesla: I Was Wrong To Short (Rating Upgrade) (NASDAQ:TSLA) | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-10-16 | 2024-09 | 0.58 | N/A | N/A | N/A |
2024-07-23 | 2024-06 | 0.62 | 0.52 | -0.1 | -16.13% |
2024-04-23 | 2024-03 | 0.46 | 0.45 | -0.01 | -2.17% |
2024-01-24 | 2023-12 | 0.75 | 0.71 | -0.04 | -5.33% |
2023-10-18 | 2023-09 | 0.72 | 0.66 | -0.06 | -8.33% |
2023-07-19 | 2023-06 | 0.83 | 0.91 | 0.08 | 9.64% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-18 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-18 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-10-18 | Wedbush | Upgrade | Outperform | Outperform |
2023-10-18 | Citigroup | Upgrade | Neutral | Neutral |
2023-10-18 | Roth MKM | Upgrade | Neutral | Neutral |
2023-10-18 | Guggenheim | Upgrade | Sell | Sell |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-31 | BAGLINO ANDREW D | Officer | 31.23K | Sale |
2024-05-05 | DENHOLM ROBYN M | Director | 15.00K | Sale |
2021-10-26 | EHRENPREIS IRA MATTHEW | Director | 205.73K | Sale |
2023-08-03 | KIRKHORN ZACHARY | Chief Financial Officer | 193.79K | Sale |
2024-06-02 | MURDOCH JAMES RUPERT | Director | 407.30K | Conversion of Exercise of derivative security |
2023-03-07 | MUSK ELON REEVE | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 222.49M | 58.24B | 7.01% |
2023-06-29 | Blackrock Inc. | 185.89M | 48.66B | 5.86% |
2023-06-29 | State Street Corporation | 104.12M | 27.25B | 3.28% |
2023-06-29 | Geode Capital Management, LLC | 51.66M | 13.52B | 1.63% |
2023-06-29 | Capital World Investors | 42.27M | 11.07B | 1.33% |
2023-06-29 | FMR, LLC | 28.77M | 7.53B | 0.91% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 84.02M | 21.99B | 2.65% |
2023-06-29 | Vanguard 500 Index Fund | 64.14M | 16.79B | 2.02% |
2023-05-30 | Fidelity 500 Index Fund | 30.10M | 6.14B | 0.95% |
2023-08-30 | SPDR S&P 500 ETF Trust | 29.68M | 7.66B | 0.94% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 25.05M | 6.46B | 0.79% |
2023-08-30 | iShares Core S&P 500 ETF | 25.20M | 6.50B | 0.79% |
Split | Date |
---|---|
3 : 1 | 2022-08-25 |
5 : 1 | 2020-08-31 |
So musk is giving employees paid sick leave and building ventilators to give them out for free seems to me like he isn’t worried about money
Who is still delivering vehicles?
$TSLA fed will start buying shares to hold the market up. Unlimited money. The bottom was $350 - onward back to $1000
$TSLA was limp, now getting hard as a rock. Shooting way up. Should be $535 EOD
$TSLA just broke resistance. Could shoot up to $530 before leveling out.
$TSLA going to $530 at least
$TSLA about to hit $600
$TSLA running up to $530. Told you so.
Few more days of pumping this up and then probably a sell-off on Friday $TSLA
$TSLA will climb back up to $530 today. Bottom is over. Tesla fanboys and the cult won’t allow it.m to dip. Neither will the FED propping it up. And what about those who paid $725 per share. They’re gonna pump it back up.
Trending upwards like Friday. Will probably close at $525 $TSLA
$TSLA cult is too strong. The resistance at $495-$500 is too strong. This going to go back up to $530 at LEAST.
$TSLA going to do the same as last week and go back up to $550
$$NPSX Covid19 treatment
https://microcapdaily.com/the-inside-scoop-on-inspyr-therapeutics-inc-otcmkts-nspx/125607